Cara Therapeutics | CARA - Ordinary Share Capital


Cara Therapeutics reported $9.38M in Ordinary Share Capital for its fiscal quarter ending in March of 2026.





Ordinary Share Capital Change Date
Acadia Pharmaceuticals USD 171.09M 1.9M Mar/2026
Alterity Therapeutics Limited AUD 10.88B 10.66B Dec/2025
Cara Therapeutics USD 9.38M 2.01K Mar/2026
Cassava Sciences USD 48.31M 0 Mar/2026
Chugai Pharma JPY 1.65B 460K Jun/2026
Cipla INR 807.78M 17K Mar/2026
Clal Biotechnology ILS 1.61M 0 Dec/2022
Compugen USD 94.55M 1000 Mar/2026
CSL USD 482.13M 93.87M Dec/2025
Grifols EUR 680.58M 846.11K Dec/2025
Halozyme Therapeutics USD 114.04M 4.48M Jun/2026
J&J USD 2.41B 1.35M Mar/2026
Neurocrine Biosciences USD 100.55M 50K Jun/2026
Pacira USD 39.82M 512K Jun/2026
Pfizer USD 5.7B 0 Jun/2026
RedHill Biopharma USD 50.92B 17.62B Dec/2025
Supernus Pharmaceuticals USD 58.16M 124K Jun/2026
Vanda Pharmaceuticals USD 58K 0 Dec/2024